CompletedInterventionalNot ApplicableLast updated Aug 14, 2026

The Safety and Efficacy of Good Feeling Power® for IBD Patients

An Open-Label Pilot Study to Determine Safety and Efficacy of Good Feeling Power® (a Dietary Supplement) in Patients With Either Ulcerative Colitis or Colonic/Ileal Crohn's Disease

Overview

ClinicalTrials.gov ID: NCT07766733
Lead Sponsor: Good Feeling Products GmbHINDUSTRY
Brief Summary: This open-label pilot study aims to evaluate the safety and efficacy of the dietary supplement Good Feeling Power® for patients with mild-to-moderate ulcerative colitis and colonic/ileal Crohn's disease.
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Nov 6, 2023Actual
Primary Completion Date: Jun 20, 2025Actual
Completion Date: Jun 20, 2025Actual

Study Record Dates

First Submitted: Aug 6, 2026
First Submitted that Met QC Criteria: Aug 11, 2026
First Posted: Aug 14, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 11, 2026
Last Update Posted: Aug 14, 2026Actual
Last Verified: Aug 2026

NCT00928681Completed

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

NCT05549323Terminated

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT04209556Withdrawn

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

NCT02840721Completed

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

NCT06260267Withdrawn

A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

NCT01164904Terminated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis